Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
3.430
-0.020 (-0.58%)
Dec 3, 2024, 11:47 AM EST - Market open
Scinai Immunotherapeutics Employees
Scinai Immunotherapeutics had 31 employees as of December 31, 2023. The number of employees decreased by 2 or -6.06% compared to the previous year.
Employees
31
Change (1Y)
-2
Growth (1Y)
-6.06%
Revenue / Employee
$14,581
Profits / Employee
$151,484
Market Cap
2.93M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Xylo Technologies | 84 |
| NovaBay Pharmaceuticals | 26 |
| ENDRA Life Sciences | 21 |
| Petros Pharmaceuticals | 21 |
| InMed Pharmaceuticals | 13 |
| Phio Pharmaceuticals | 9 |
| Quoin Pharmaceuticals | 4 |
| Bone Biologics | 2 |
SCNI News
- 6 days ago - Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board - PRNewsWire
- 11 days ago - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - PRNewsWire
- 4 weeks ago - Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024 - PRNewsWire
- 2 months ago - Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies - PRNewsWire
- 3 months ago - IBN Announces Latest Episode of The BioMedWire Podcast featuring Amir Reichman, CEO of Scinai Immunotherapeutics Ltd. - GlobeNewsWire
- 3 months ago - Scinai Regains Full Compliance with Nasdaq Listing Requirements - PRNewsWire
- 3 months ago - Scinai Announces Closing of Loan Restructuring Agreement with European Investment Bank Converting Approximately $29 million of Debt to Preferred Equity and Leaving Debt Balance of $273,000 - PRNewsWire
- 3 months ago - Scinai Immunotherapeutics Ltd. (SCNI) Q2 2024 Earnings Call Transcript - Seeking Alpha